You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 11, November 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Liver Transplantation
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Model for End-stage Liver Disease

Did the New Liver Allocation Policy Affect Waiting List Mortality?

Mary T. Austin, MD, MPH; Benjamin K. Poulose, MD, MPH; Wayne A. Ray, PhD; Patrick G. Arbogast, PhD; Irene D. Feurer, PhD; C. Wright Pinson, MD, MBA

Arch Surg. 2007;142(11):1079-1085.

Objective  To examine the impact of the Model for End-stage Liver Disease (MELD) on waiting list mortality.

Design  Interrupted time series with a nominal inception point of the intervention on February 27, 2002.

Setting  United Network for Organ Sharing Standard Transplant Analysis and Research file data from March 1, 1999, to July 30, 2004.

Participants  All adult candidates on the waiting list for liver transplantation in the United States during the study period.

Intervention  Implementation of the MELD policy.

Main Outcome Measures  Waiting list mortality, waiting time to transplantation, number of new registrants, and posttransplantation survival.

Results  Although no preintervention trend was identified, the policy change was associated with an immediate effect of increasing waiting list mortality by 2.2 deaths per 1000 registrants per month (from approximately 11 to 13 deaths per 1000 registrants per month; 95% confidence interval [CI], 1.1 to 3.4; P = .001) followed by a postintervention decline in waiting list mortality over time (–0.09 death per 1000 registrants per month; 95% CI, –0.16 to –0.03; P <.001). An immediate effect of decreased waiting time was also noted (from approximately 294 to 250 days; –44.4 days; 95% CI, –77.1 to –11.7 days; P <.001), which reached a new, lower postintervention steady state. The intervention had no effect on the number of new registrants listed per month or on 3- and 6-month posttransplantation survival.

Conclusion  After an initial increase in waiting list mortality, the implementation of the MELD-based allocation policy was associated with an overall decline in waiting list mortality and time to transplantation.


Author Affiliations: Departments of Surgery (Drs Austin, Poulose, and Feurer), Preventive Medicine (Drs Ray and Arbogast), and Biostatistics (Drs Arbogast and Feurer) and Division of Hepatobiliary Surgery and Liver Transplantation (Dr Pinson), Vanderbilt University Medical Center, Nashville, Tennessee.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Waiting List Mortality Among Children Listed for Heart Transplantation in the United States
Almond et al.
Circulation 2009;119:717-727.
ABSTRACT | FULL TEXT  

Patient Selection in Liver Transplant: When Is It the Right Time to List?
Selvaggi
Mayo Clin Proc. 2008;83:140-142.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.